Janux Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell JANX and other ETFs, options, and stocks.

About JANX

Janux Therapeutics, Inc. operates a preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded in June 2017 and is headquartered in San Diego, CA. 

CEO
David Campbell
CEODavid Campbell
Employees
33
Employees33
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2017
Founded2017
Employees
33
Employees33

JANX Key Statistics

Market cap
634.50M
Market cap634.50M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
62.52K
Average volume62.52K
High today
$15.39
High today$15.39
Low today
$13.72
Low today$13.72
Open price
$13.72
Open price$13.72
Volume
69.07K
Volume69.07K
52 Week high
$22.61
52 Week high$22.61
52 Week low
$9.39
52 Week low$9.39

JANX Earnings

-$0.62
-$0.41
-$0.21
$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Mar 17, After Hours
ActualExpected Mar 17, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.